Albany Molecular Research (AMRI) Misses Q4 EPS by 5c; Guides FY15 EPS
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Price: $21.74 --0%
Financial Fact:
Recurring royalties: 1.06M
Today's EPS Names:
CMCT, STEX, PWCM, More
Financial Fact:
Recurring royalties: 1.06M
Today's EPS Names:
CMCT, STEX, PWCM, More
Join SI Premium – FREE
Albany Molecular Research (NASDAQ: AMRI) reported Q4 EPS of $0.28, $0.05 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $86.6 million versus the consensus estimate of $91.9 million.
Albany Molecular Research sees FY2015 EPS of $0.80-$0.90, versus the consensus of $0.90.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
